What is the management plan for a patient with degenerative changes in the tibiofemoral and patellofemoral joints, bilateral meniscal tears, and marrow edema, presenting with significant knee pain and limited mobility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for Degenerative Knee Changes with Bilateral Meniscal Tears

The appropriate ICD-10 codes for this case are M17.0 (Bilateral primary osteoarthritis of knee) as the primary diagnosis, with M23.203 (Derangement of unspecified meniscus due to old tear or injury, unspecified knee, bilateral) as a secondary code to capture the bilateral meniscal pathology.

Primary Diagnosis Code

  • M17.0 (Bilateral primary osteoarthritis of knee) is the most accurate primary code because the imaging demonstrates degenerative changes affecting all three compartments (medial tibiofemoral, lateral tibiofemoral, and patellofemoral) with characteristic features of osteoarthritis including narrowed joint spaces, irregular articular surfaces, subchondral marrow edema, and marginal osteophytes 1.

Secondary Diagnosis Code

  • M23.203 (Derangement of unspecified meniscus due to old tear or injury, unspecified knee, bilateral) should be added as a secondary code because the imaging reveals branching tears of both the medial and lateral menisci in both horns and body segments 1, 2.
  • The meniscal tears in this context are degenerative rather than acute traumatic tears, as evidenced by the extensive degenerative changes throughout the joint and the complex branching pattern described 2.

Additional Coding Considerations

  • M25.469 (Effusion, unspecified knee, bilateral) may be considered if the periarticular soft tissue edema represents significant joint effusion, as effusion is associated with increased knee pain and progression of osteoarthritis 1, 3.
  • M25.569 (Pain in unspecified knee, bilateral) can be added if documenting the symptomatic nature of the condition for billing purposes, though this is often implied by the primary diagnosis 1.

Bone Marrow Edema Documentation

  • The subchondral marrow edema noted in the medial compartment is a significant finding that indicates active disease and is associated with increased knee pain 1, 4.
  • Bone marrow lesions (BMLs) are readily depicted on MRI and new or increasing BMLs are associated with increased knee pain and risk of progression 1.
  • While bone marrow edema is captured within the osteoarthritis diagnosis, documenting its presence in clinical notes is important as it may influence treatment decisions and prognosis 4, 5.

Common Coding Pitfalls to Avoid

  • Avoid using M23.2 codes for acute meniscal tears when the clinical and imaging context clearly indicates degenerative meniscal pathology associated with osteoarthritis 2.
  • Do not code each compartment separately (M17.2 for medial, M17.3 for lateral) when bilateral disease affecting multiple compartments is present; M17.0 is more appropriate 1.
  • Avoid omitting the bilateral designation when both knees are affected, as this impacts treatment planning and reimbursement 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of Degenerative Meniscus Tears.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2023

Research

Bone marrow edema of the knee: a narrative review.

Archives of orthopaedic and trauma surgery, 2024

Related Questions

What is the treatment for marrow edema in the knee identified on Magnetic Resonance Imaging (MRI)?
What is the most significant factor in the development of a 34-year-old male's progressive left knee pain, who has a history of anterior cruciate ligament (ACL) surgery, a family history of rheumatoid arthritis (RA), and presents with swelling, tenderness along the joint line, and an externally rotated left tibia?
What are the next steps in managing a 44-year-old male patient with bilateral knee pain, particularly with a sensation of bone-to-bone pain in the left knee, who is currently prescribed ibuprofen (ibuprofen) 400 mg three times a day as needed and is using a knee sleeve?
What is the recommended treatment for a 55-year-old patient with anterior and posterior knee swelling and pain after heavy lifting and stair climbing, without any history of injury or trauma?
What is the treatment for a 58-year-old male with knee pain, contusions of the medial tibial plateau, a horizontal oblique meniscus tear, and osteoarthritis after a pivot injury?
What is the diagnosis and management for a patient with PFT results showing reduced FEV1/FVC ratio and decreased FEV1, indicating obstructive lung disease?
Can a patient with type 1 diabetes (T1D) receive long-term management according to the latest International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines?
What is the recommended approach for transfusing Fresh Frozen Plasma (FFP) in a massive transfusion scenario?
What is the appropriate dose of amoxyclav (amoxicillin-clavulanate) for a pediatric patient with type 1 diabetes and potentially impaired renal function?
What is the most likely cause of gastrointestinal bleeding in a 40-year-old man with acute hematemesis, no history of liver disease, normal liver function tests, and no previous similar episodes?
How does a healthcare provider prescribe methotrexate (methotrexate sodium) to a patient with a condition such as rheumatoid arthritis, psoriasis, or cancer, considering their medical history, age, kidney function, and other medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.